In summary, the metabolomic profile of Egln3_KO AML cells cocultured with CD81+ Erys exhibited an opposite trend compared with that of NT AML cells cocultured with CD81+ Erys, underscoring the critical role of Egln3 in this metabolic adaptation. Here, CD81 is linked to acute myeloid leukemia.